Novel Compounds and Compositions as Cathepsin S Inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11740414

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVENTIS PHARMACEUTICALS INCBRIDGEWATER NEW JERSEY 08807

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aldous, David J Gillette, NJ 22 134
Li, Jiayo Foster City, CA 3 2
Thurairatnam, Sukanthini Bedminster, NJ 22 164

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation